Exchange Traded Concepts Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| CAREDX, INC.CDNA | 2.68% | $1.85M | 42,385 |
| GUARDANT HEALTH, INC.GH | 2.31% | $1.60M | 9,878 |
| Lonza Group AG | 1.85% | $1.58M | 1,841 |
| NATERA, INC.NTRA | 2.23% | $1.54M | 5,764 |
| Twist Bioscience CorpTWST | 2.23% | $1.54M | 16,853 |
| THERMO FISHER SCIENTIFIC INCORPORATEDTMO | 2.18% | $1.51M | 2,621 |
| Siemens Healthineers AG | 1.85% | $1.47M | 30,197 |
| MEDPACE HOLDINGS, INC.MEDP | 2.12% | $1.47M | 2,539 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATIONADPT | 2.11% | $1.46M | 64,619 |
| IQVIA HOLDINGS INCIQV | 2.10% | $1.45M | 6,182 |
| ILLUMINA, INC.ILMN | 2.09% | $1.44M | 7,028 |
| ARROWHEAD PHARMACEUTICALS, INC.ARWR | 2.08% | $1.44M | 16,973 |
| Tecan Group AG | 1.66% | $1.41M | 4,974 |
| REGENERON PHARMACEUTICALS, INC.REGN | 1.97% | $1.36M | 1,789 |
| GLAUKOS CORPORATIONGKOS | 1.92% | $1.32M | 7,940 |
| VERTEX PHARMACEUTICALS INCORPORATEDVRTX | 1.91% | $1.32M | 2,773 |
| STRYKER CORPORATIONSYK | 1.91% | $1.32M | 4,057 |
| LIVANOVA PLCLIVN | 1.87% | $1.29M | 16,115 |
| Koninklijke Philips N.V. | 1.62% | $1.29M | 42,743 |
| EUROFINS SCIENTIFIC SE | 1.59% | $1.27M | 14,056 |
| Roche Holding AG | 1.47% | $1.25M | 2,318 |
| INCYTE CORPORATIONINCY | 1.80% | $1.25M | 10,419 |
| ABBOTT LABORATORIESABT | 1.79% | $1.24M | 11,713 |
| AxoGen, Inc.AXGN | 1.77% | $1.22M | 28,991 |
| BOSTON SCIENTIFIC CORPORATIONBSX | 1.73% | $1.19M | 25,562 |
| Grail IncGRAL | 1.72% | $1.19M | 17,377 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL | 1.71% | $1.18M | 5,092 |
| DANAHER CORPORATIONDHR | 1.67% | $1.15M | 5,923 |
| PENUMBRA, INC.PEN | 1.65% | $1.14M | 3,558 |
| ARTIVION, INC.AORT | 1.64% | $1.13M | 42,246 |
| TEMPUS AI, INC.TEM | 1.63% | $1.13M | 25,657 |
| IRHYTHM HOLDINGS, INC.IRTC | 1.58% | $1.10M | 9,349 |
| CONMED CORPORATIONCNMD | 1.58% | $1.09M | 23,645 |
| Qiagen N.V. | 1.58% | $1.09M | 26,387 |
| EDWARDS LIFESCIENCES CORPORATIONEW | 1.55% | $1.07M | 12,485 |
| CRISPR Therapeutics AG | 1.53% | $1.06M | 22,018 |
| GLOBUS MEDICAL, INC.GMED | 1.52% | $1.05M | 13,339 |
| BIO-RAD LABORATORIES, INC.BIO | 1.51% | $1.04M | 3,201 |
| BRISTOL-MYERS SQUIBB COMPANYBMY | 1.50% | $1.04M | 15,926 |
| INTUITIVE SURGICAL, INC.ISRG | 1.50% | $1.04M | 2,934 |
| GE HEALTHCARE TECHNOLOGIES INC.GEHC | 1.50% | $1.03M | 15,208 |
| MODERNA, INC.MRNA | 1.48% | $1.03M | 18,698 |
| SMITH & NEPHEW PLC | 1.08% | $1.01M | 48,085 |
| BECTON, DICKINSON AND COMPANYBDX | 1.45% | $1.01M | 6,072 |
| DIASORIN S.P.A. | 1.26% | $1.00M | 10,522 |
| AGILENT TECHNOLOGIES, INC.A | 1.42% | $981.87K | 7,096 |
| Veracyte IncVCYT | 1.38% | $955.35K | 20,625 |
| NOVANTA INC.NOVT | 1.33% | $916.45K | 6,429 |
| BIOMARIN PHARMACEUTICAL INC.BMRN | 1.31% | $905.10K | 15,080 |
| NOVOCURE LIMITED | 1.30% | $901.46K | 60,745 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.